Phone
Terremoto Biosciences
EA Policies for Single Patient
Currently, Terremoto does not offer expanded access as our investigational drugs are undergoing evaluation in early clinical trials to optimize the dosing regimen and better understand safety and tolerability. At this early stage of development, there are insufficient data to support expanded access.